MD3322438T2 - Inhibitori ai IL-8 pentru utilizare în tratamentul anumitor tulburări urologice - Google Patents

Inhibitori ai IL-8 pentru utilizare în tratamentul anumitor tulburări urologice

Info

Publication number
MD3322438T2
MD3322438T2 MDE20180523T MDE20180523T MD3322438T2 MD 3322438 T2 MD3322438 T2 MD 3322438T2 MD E20180523 T MDE20180523 T MD E20180523T MD E20180523 T MDE20180523 T MD E20180523T MD 3322438 T2 MD3322438 T2 MD 3322438T2
Authority
MD
Moldova
Prior art keywords
treatment
inhibitors
urological disorders
pbs
oab
Prior art date
Application number
MDE20180523T
Other languages
English (en)
Inventor
Marcello Allegretti
Andrea Aramini
Maria Candida Cesta
Gianluca Bianchini
Laura Brandolini
Patrizia Angelico
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of MD3322438T2 publication Critical patent/MD3322438T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Prezenta invenţie se referă la compuşi inhibitori ai IL-8, de preferinţă inhibitori duali ai receptorilor CXCR1 / CXCR2, utili în tratamentul şi / sau prevenirea cistitei interstiţiale / sindromului dureros al vezicii urinare (IC / PBS) şi / sau a vezicii hiperactive (OAB), inclusiv IC / PBS şi / sau OAB induse de terapia anticancer. Metodele de tratament şi / sau prevenire, combinaţiile şi kiturile care cuprind inhibitorii IL-8 menţionaţi sunt, de asemenea, acoperite în acestea.
MDE20180523T 2015-07-14 2016-07-12 Inhibitori ai IL-8 pentru utilizare în tratamentul anumitor tulburări urologice MD3322438T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15176726.6A EP3117835A1 (en) 2015-07-14 2015-07-14 Il-8 inhibitors for use in the treatment of certain urological disorders
PCT/EP2016/066511 WO2017009323A1 (en) 2015-07-14 2016-07-12 Il-8 inhibitors for use in the treatment of certain urological disorders

Publications (1)

Publication Number Publication Date
MD3322438T2 true MD3322438T2 (ro) 2022-01-31

Family

ID=53757997

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20180523T MD3322438T2 (ro) 2015-07-14 2016-07-12 Inhibitori ai IL-8 pentru utilizare în tratamentul anumitor tulburări urologice

Country Status (25)

Country Link
US (1) US20180200231A1 (ro)
EP (2) EP3117835A1 (ro)
JP (1) JP6937738B2 (ro)
KR (1) KR102622924B1 (ro)
CN (1) CN107921105B (ro)
AU (1) AU2016292902B2 (ro)
BR (1) BR112018000676A2 (ro)
CA (1) CA2991810A1 (ro)
CY (1) CY1125437T1 (ro)
DK (1) DK3322438T3 (ro)
EA (2) EA201890312A1 (ro)
ES (1) ES2894077T3 (ro)
HR (1) HRP20211574T1 (ro)
HU (1) HUE056439T2 (ro)
IL (1) IL256413B (ro)
LT (1) LT3322438T (ro)
MA (1) MA42437A (ro)
MD (1) MD3322438T2 (ro)
MX (1) MX2018000539A (ro)
PL (1) PL3322438T3 (ro)
PT (1) PT3322438T (ro)
RS (1) RS62413B1 (ro)
SI (1) SI3322438T1 (ro)
WO (1) WO2017009323A1 (ro)
ZA (1) ZA201708608B (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3342407A1 (en) * 2017-01-03 2018-07-04 Dompé farmaceutici S.p.A. Il-8 inihibitors for use in the treatment of some urological disorders
CN114712377B (zh) * 2022-04-26 2023-08-15 江苏师范大学 断血流皂苷a在制造药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
SI1776336T1 (sl) * 2004-03-23 2010-01-29 Dompe Spa Derivati 2-fenilpropionske kisline in farmacevtski sestavki, ki jih vsebujejo
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
US20100166739A1 (en) * 2008-12-30 2010-07-01 Lipella Paharmaceuticals Inc. Methods and Compositions for Diagnosing Urological Disorders
KR101458947B1 (ko) * 2013-03-05 2014-11-12 국립암센터 인터루킨-８ 앱타머 및 이의 용도

Also Published As

Publication number Publication date
EA202190242A1 (ru) 2021-11-30
CN107921105A (zh) 2018-04-17
LT3322438T (lt) 2021-10-25
PT3322438T (pt) 2021-10-01
EA201890312A1 (ru) 2018-08-31
MX2018000539A (es) 2018-09-06
AU2016292902B2 (en) 2021-06-03
DK3322438T3 (da) 2021-10-18
PL3322438T3 (pl) 2022-01-03
HRP20211574T1 (hr) 2022-02-04
JP6937738B2 (ja) 2021-09-22
WO2017009323A1 (en) 2017-01-19
ZA201708608B (en) 2019-05-29
EP3322438B1 (en) 2021-09-08
MA42437A (fr) 2021-06-02
US20180200231A1 (en) 2018-07-19
CA2991810A1 (en) 2017-01-19
IL256413B (en) 2021-04-29
CN107921105B (zh) 2022-08-02
BR112018000676A2 (pt) 2018-09-18
KR20180030075A (ko) 2018-03-21
JP2018520184A (ja) 2018-07-26
HUE056439T2 (hu) 2022-02-28
NZ739077A (en) 2023-12-22
ES2894077T3 (es) 2022-02-11
IL256413A (en) 2018-02-28
SI3322438T1 (sl) 2021-11-30
AU2016292902A1 (en) 2018-01-18
KR102622924B1 (ko) 2024-01-09
EP3117835A1 (en) 2017-01-18
CY1125437T1 (el) 2023-03-24
EP3322438A1 (en) 2018-05-23
RS62413B1 (sr) 2021-10-29

Similar Documents

Publication Publication Date Title
MD3371190T2 (ro) Compuși heterociclici ca inhibitori PI3K-gamma
MD3368541T2 (ro) Compoziții și procedee de inhibare a activității arginazei
EA201690456A1 (ru) Способы лечения и предотвращения эндотелиальной дисфункции с применением бардоксолона метила или его аналогов
EA201890111A1 (ru) Замещенные производные оксопиридина
CY1125025T1 (el) 2-φορμυλ-3-υδροξυφαινυλοξυμεθυλ ενωσεις ικανες ρυθμισης αιμοσφαιρινης
EA201991556A1 (ru) Ингибиторы фосфодиэстеразы и способы лечения микробной инфекции
MX2019009117A (es) Anticuerpos anti alfa-sinucleina y usos de los mismos.
EA201790142A1 (ru) Лечение лейкоза ингибиторами гистондеацетилазы
EA201892008A1 (ru) Соединения и способы лечения неврологических и сердечно-сосудистых состояний
EA201890185A1 (ru) Способы лечения опосредованных гепсидином нарушений
DK2243772T3 (da) Hidtil ukendte P2X7R-antagonister og deres anvendelse
MD3762368T2 (ro) Compuși diol aminopirazină ca inhibitori ai PI3K-Y
EA201790745A1 (ru) Трициклические соединения
EA201692470A1 (ru) Фармацевтические комбинации
EA202091020A1 (ru) Замещенные имидазопиридинамиды и их применение
EA201791227A1 (ru) РЕЖИМ ДОЗИРОВАНИЯ АНТАГОНИСТОВ MAdCAM
EA202091482A1 (ru) Антитела
MD3697789T2 (ro) Derivați imidazol condensați substituiți cu grupări hidroxi terțiare ca inhibitori PI3K-GAMA
EA201891710A1 (ru) Терапевтические соединения
EA202091478A1 (ru) Антитела
EA201891610A1 (ru) Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
CY1125437T1 (el) Αναστολεις της il-8 προς χρηση στη θεραπεια ορισμενων ουρολογικων διαταραχων
MX2018008614A (es) Inhibidores de il-8 para usarse en el tratamiento de neuropatia periferica inducida por quimioterapia.
MD3846810T2 (ro) Dozare cronică nocturnă a lasmiditanului pentru prevenirea migrenei
EA202090266A1 (ru) Ингибиторы mpo для применения в медицине

Legal Events

Date Code Title Description
MM4A Patent for invention definitely lapsed due to non-payment of fees